FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035493973> ?p ?o ?g. }

• W2035493973 endingPage "6" @default.
• W2035493973 startingPage "1" @default.
• W2035493973 abstract "Neuroimmunophilin ligands (NILs) are drugs derived from the immunosuppressant FK506 (tacrolimus) that have been shown to have variable efficacy in reversing neuronal degeneration and preventing cell death. In a wide range of animal models mimicking Parkinson's disease, dementia and even surgical nerve damage they induce re-sprouting, are neurotrophic or prevent nerve damage. The neurotrophic mechanism of action of these compounds is not known and may be dependent on the type of damage and genetic variability at the species or cellular level. Some evidence suggests that NILs may act through a family of proteins called FK506 binding proteins, some of which may regulate steroid hormone receptors. Other evidence suggests that NILs may protect neurons by upregulating the antioxidant glutathione and stimulating nerve regrowth by inducing the production of neurotrophic factors. Initial clinical trials have had mixed success. In one, patients with moderately severe Parkinson's disease showed no overall improvement in fine motor skills following 6 months of treatment by the neuroimmunophilin GPI 1485. But these patients did exhibit decreased loss of dopaminergic nerve terminals with a low dose of GPI 1485 and in fact some increase in dopaminergic terminals within 6 months of the higher dose of GPI 1485 drug treatment. As a result, a second phase II clinical trial using a patient population with less severe degeneration has been initiated concurrent with an investigation of GPI 1485 and other neuroprotective therapies funded by the National Institute of Neurological Disorders and Stroke. Another clinical trial ongoing at this time is exploring the use of a neuroimmunophilin ligand to prevent nerve degeneration and erectile dysfunction resulting from prostatectomy. In summary, neuroimmunophilins show promise to reverse some forms of neurodegeneration but exact factors that predict outcome have not been identified." @default.
• W2035493973 created "2016-06-24" @default.
• W2035493973 creator A5015918071 @default.
• W2035493973 creator A5030637514 @default.
• W2035493973 creator A5049765675 @default.
• W2035493973 date "2004-01-01" @default.
• W2035493973 modified "2023-10-13" @default.
• W2035493973 title "Neuroimmunophilins: A novel drug therapy for the reversal of neurodegenerative disease?" @default.
• W2035493973 cites W1489987913 @default.
• W2035493973 cites W1495047607 @default.
• W2035493973 cites W1834422411 @default.
• W2035493973 cites W1966218771 @default.
• W2035493973 cites W1967462135 @default.
• W2035493973 cites W1967735861 @default.
• W2035493973 cites W1974080229 @default.
• W2035493973 cites W1979177276 @default.
• W2035493973 cites W1980426146 @default.
• W2035493973 cites W1982134982 @default.
• W2035493973 cites W1983274737 @default.
• W2035493973 cites W1984754431 @default.
• W2035493973 cites W1985864216 @default.
• W2035493973 cites W1991274730 @default.
• W2035493973 cites W2004036685 @default.
• W2035493973 cites W2004391423 @default.
• W2035493973 cites W2006791750 @default.
• W2035493973 cites W2009885190 @default.
• W2035493973 cites W2015058179 @default.
• W2035493973 cites W2022405994 @default.
• W2035493973 cites W2027294322 @default.
• W2035493973 cites W2036788411 @default.
• W2035493973 cites W2037065721 @default.
• W2035493973 cites W2042740099 @default.
• W2035493973 cites W2045551622 @default.
• W2035493973 cites W2062805042 @default.
• W2035493973 cites W2077769042 @default.
• W2035493973 cites W2078034681 @default.
• W2035493973 cites W2082215172 @default.
• W2035493973 cites W2086762723 @default.
• W2035493973 cites W2111474832 @default.
• W2035493973 cites W2113100908 @default.
• W2035493973 cites W2125117018 @default.
• W2035493973 cites W2135128039 @default.
• W2035493973 cites W2137341857 @default.
• W2035493973 cites W2141419425 @default.
• W2035493973 cites W2154278641 @default.
• W2035493973 cites W2160908214 @default.
• W2035493973 cites W2175029576 @default.
• W2035493973 cites W4252192817 @default.
• W2035493973 cites W2003873952 @default.
• W2035493973 doi "https://doi.org/10.1016/j.neuroscience.2004.06.016" @default.
• W2035493973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15450348" @default.
• W2035493973 hasPublicationYear "2004" @default.
• W2035493973 type Work @default.
• W2035493973 sameAs 2035493973 @default.
• W2035493973 citedByCount "54" @default.
• W2035493973 countsByYear W20354939732012 @default.
• W2035493973 countsByYear W20354939732013 @default.
• W2035493973 countsByYear W20354939732014 @default.
• W2035493973 countsByYear W20354939732015 @default.
• W2035493973 countsByYear W20354939732016 @default.
• W2035493973 countsByYear W20354939732017 @default.
• W2035493973 countsByYear W20354939732019 @default.
• W2035493973 countsByYear W20354939732022 @default.
• W2035493973 countsByYear W20354939732023 @default.
• W2035493973 crossrefType "journal-article" @default.
• W2035493973 hasAuthorship W2035493973A5015918071 @default.
• W2035493973 hasAuthorship W2035493973A5030637514 @default.
• W2035493973 hasAuthorship W2035493973A5049765675 @default.
• W2035493973 hasConcept C126322002 @default.
• W2035493973 hasConcept C137183658 @default.
• W2035493973 hasConcept C160539049 @default.
• W2035493973 hasConcept C169760540 @default.
• W2035493973 hasConcept C170493617 @default.
• W2035493973 hasConcept C25498285 @default.
• W2035493973 hasConcept C2908647359 @default.
• W2035493973 hasConcept C513476851 @default.
• W2035493973 hasConcept C535046627 @default.
• W2035493973 hasConcept C60644358 @default.
• W2035493973 hasConcept C71924100 @default.
• W2035493973 hasConcept C86803240 @default.
• W2035493973 hasConcept C92020748 @default.
• W2035493973 hasConcept C98274493 @default.
• W2035493973 hasConcept C99454951 @default.
• W2035493973 hasConceptScore W2035493973C126322002 @default.
• W2035493973 hasConceptScore W2035493973C137183658 @default.
• W2035493973 hasConceptScore W2035493973C160539049 @default.
• W2035493973 hasConceptScore W2035493973C169760540 @default.
• W2035493973 hasConceptScore W2035493973C170493617 @default.
• W2035493973 hasConceptScore W2035493973C25498285 @default.
• W2035493973 hasConceptScore W2035493973C2908647359 @default.
• W2035493973 hasConceptScore W2035493973C513476851 @default.
• W2035493973 hasConceptScore W2035493973C535046627 @default.
• W2035493973 hasConceptScore W2035493973C60644358 @default.
• W2035493973 hasConceptScore W2035493973C71924100 @default.
• W2035493973 hasConceptScore W2035493973C86803240 @default.
• W2035493973 hasConceptScore W2035493973C92020748 @default.
• W2035493973 hasConceptScore W2035493973C98274493 @default.
• W2035493973 hasConceptScore W2035493973C99454951 @default.

• next